These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34943879)

  • 21. Insulin signaling in the heart is impaired by growth hormone: a direct and early event.
    Muñoz MC; Piazza VG; Burghi V; Giani JF; Martinez CS; Cicconi NS; Muia NV; Fang Y; Lavandero S; Sotelo AI; Bartke A; Pennisi PA; Dominici FP; Miquet JG
    J Mol Endocrinol; 2022 Aug; 69(2):357-376. PubMed ID: 35608964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebrafish transgenic model.
    Kuradomi RY; Figueiredo MA; Lanes CF; da Rosa CE; Almeida DV; Maggioni R; Silva MD; Marins LF
    Transgenic Res; 2011 Jun; 20(3):513-21. PubMed ID: 20640508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The growth hormone insulin-like growth factor axis in kidney revisited.
    Hammerman MR; Miller SB
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F1-14. PubMed ID: 8393619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.
    Kumar PA; Brosius FC; Menon RK
    Curr Diabetes Rev; 2011 Jan; 7(1):50-5. PubMed ID: 21067510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The growth hormone and insulin-like growth factor 1 axis in cattle during the peri-ovulatory period activates the synthesis and release of oviductal contraction related substances.
    Kodithuwakku SP; Akthar I; Muhandiram S; Wijayagunawardhana MPB; Miyamoto A
    Mol Reprod Dev; 2021 Mar; 88(3):201-210. PubMed ID: 33559208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining human insulin-like growth factor I gene regulation.
    Mukherjee A; Alzhanov D; Rotwein P
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E519-29. PubMed ID: 27406741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent.
    Flyvbjerg A; Bennett WF; Rasch R; van Neck JW; Groffen CA; Kopchick JJ; Scarlett JA
    Kidney Int; 1999 Dec; 56(6):2048-54. PubMed ID: 10594780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
    Oh Y
    Kidney Res Clin Pract; 2012 Mar; 31(1):26-37. PubMed ID: 26889406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth.
    Wang J; Zhou J; Cheng CM; Kopchick JJ; Bondy CA
    J Endocrinol; 2004 Feb; 180(2):247-55. PubMed ID: 14765976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
    Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA
    Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GH/IGF-1 Signaling and Current Knowledge of Epigenetics; a Review and Considerations on Possible Therapeutic Options.
    Álvarez-Nava F; Lanes R
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28981462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The growth hormone-insulin-like growth factor axis in kidney.
    Hammerman MR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F503-14. PubMed ID: 2679142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
    Mauras N; Merimee T; Rogol AD
    Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a growth hormone-releasing factor antagonist on compensatory renal growth, insulin-like growth factor-I (IGF-I), and IGF-I receptor gene expression after unilateral nephrectomy in immature rats.
    Mulroney SE; Lumpkin MD; Roberts CT; LeRoith D; Haramati A
    Endocrinology; 1992 May; 130(5):2697-702. PubMed ID: 1315253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic suppression of GH-IGF-1 activity, combined with lifelong caloric restriction, prevents age-related renal damage and prolongs the life span in rats.
    Zha Y; Taguchi T; Nazneen A; Shimokawa I; Higami Y; Razzaque MS
    Am J Nephrol; 2008; 28(5):755-64. PubMed ID: 18434714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.
    Chen NY; Chen WY; Bellush L; Yang CW; Striker LJ; Striker GE; Kopchick JJ
    Endocrinology; 1995 Feb; 136(2):660-7. PubMed ID: 7835300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type II SOCS as a feedback repressor for GH-induced Igf1 expression in carp hepatocytes.
    Jiang X; Xiao J; He M; Ma A; Wong AO
    J Endocrinol; 2016 May; 229(2):171-86. PubMed ID: 27271287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.
    Somm E; Bonnet N; Martinez A; Marks PM; Cadd VA; Elliott M; Toulotte A; Ferrari SL; Rizzoli R; Hüppi PS; Harper E; Melmed S; Jones R; Aubert ML
    J Clin Invest; 2012 Sep; 122(9):3295-306. PubMed ID: 22850878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage.
    Zha Y; Le VT; Higami Y; Shimokawa I; Taguchi T; Razzaque MS
    Endocrinology; 2006 Dec; 147(12):5690-8. PubMed ID: 16959832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.